Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-ResistantKlebsiella pneumoniaein Transplant Recipients

New β-lactam-β-lactamase inhibitor combinations in clinical development

(2013) David M. Shlaes   Annals of the New York Academy of Sciences

Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems

(2013) Jae H. Hong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

(2012) Zubair A. Qureshi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of ISKpn7and Deletions inblaKPCGene Expression

(2012) Thierry Naas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials

(2012) P. Prasad et al.   CLINICAL INFECTIOUS DISEASES

Klebsiella pneumoniaecarbapenemase (KPC)-producingKlebsiella pneumoniae: a review of epidemiological and clinical aspects

(2012) Rosemeri Maurici da Silva et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients

(2012) Jayant S. Kalpoe et al.   LIVER TRANSPLANTATION

Klebsiella pneumoniaeOuter Membrane Porins OmpK35 and OmpK36 Play Roles in both Antimicrobial Resistance and Virulence

(2011) Yu-Kuo Tsai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

(2011) N. Gupta et al.   CLINICAL INFECTIOUS DISEASES

Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment

(2011) O. Zarkotou et al.   CLINICAL MICROBIOLOGY AND INFECTION

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient

(2011) C. Rodríguez-Avial et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multiplex PCR for detection of acquired carbapenemase genes

(2011) Laurent Poirel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria

(2011) Ryan S. Arnold et al.   SOUTHERN MEDICAL JOURNAL

Combating evolution with intelligent design: the neoglycoside ACHN-490

(2010) Eliana S Armstrong et al.   CURRENT OPINION IN MICROBIOLOGY

Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation

(2010) Gopi Patel et al.   Current Opinion in Organ Transplantation

Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae

(2010) Caroline Dallenne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiplex Real-Time PCR Assay for Detection and Classification of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) Variants

(2010) L. Chen et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study

(2010) O. Zarkotou et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan

(2009) Abhijeet S. Nadkarni et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18  -Lactamases

(2009) D. J. Wolter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital

(2009) T. D. Gootz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

(2009) Joshua D. Hartzell et al.   CLINICAL INFECTIOUS DISEASES

An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes

(2009) Maria Souli et al.   CLINICAL INFECTIOUS DISEASES

Colistin in the 21st century

(2009) Roger L Nation et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae

(2009) Leanne B. Gasink et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK

(2009) M. Doumith et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Genetic Structures at the Origin of Acquisition of the  -Lactamase blaKPC Gene

(2008) T. Naas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES